Related Experiment Video
Updated: May 2, 2026
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Predicting obstructive sleep apnea hypopnea syndrome using three-dimensional optical devices: A systematic review
Beibei Chen1, Rongkai Cao1, Danni Song1
1Shanghai Engineering Research Center of Tooth Restoration and Regeneration & Tongji Research Institute of Stomatology & Department of Orthodontics, Stomatological Hospital and Dental School, Tongji University, Shanghai, China.
Three-dimensional (3D) optical devices show promise for diagnosing obstructive sleep apnea hypopnea syndrome (OSAHS). Stereophotogrammetry-based devices are particularly effective, though more clinical data is needed for early OSAHS detection.
Area of Science:
- Medical Imaging
- Digital Health
- Sleep Medicine
Background:
- Obstructive sleep apnea hypopnea syndrome (OSAHS) is a significant global health issue.
- Accurate diagnosis of OSAHS is crucial for effective patient management.
- Advancements in digital technology offer new diagnostic possibilities.
Purpose of the Study:
- To systematically review the literature on the accuracy of 3D optical devices for OSAHS diagnosis.
- To assess the potential of 3D optical devices in identifying OSAHS prevalence and severity.
Main Methods:
- A comprehensive literature search was performed across major scientific databases up to April 2024.
- Included studies focused on the diagnostic utility of 3D optical devices for OSAHS.
- Risk of bias was assessed using the QUADAS-2 guideline.
Main Results:
- Ten studies met the inclusion criteria from 3216 initial results.
- Utilized 3D optical technologies included structured light scanners, stereophotogrammetry, and RGB-D cameras.
- Stereophotogrammetry demonstrated significant potential for OSAHS prediction.
Conclusions:
- 3D optical devices offer a promising avenue for OSAHS diagnosis, potentially enhancing accuracy, reducing costs, and improving efficiency.
- Further clinical validation is required to support the widespread adoption of these technologies for early OSAHS detection.
